CONNECT WITH US
HealthTech

HealthTech

HIV services plunge at four providers in Uganda and Zimbabwe after U.S. aid cuts

Medical Xpress logo

Published on

Add as a preferred source on Google
HIV services plunge at four providers in Uganda and Zimbabwe after U.S. aid cuts

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A new study from the London School of Economics and Political Science (LSE) and Duke University, published in The Lancet Global Health, documents severe and sustained declines in HIV service delivery for some of the world's most vulnerable populations at four nongovernmental organizations in Uganda and Zimbabwe following the cuts to U.S. foreign aid in 2025.

The research, led by Dr. Henry Cust, LSE fellow in the Department of Health Policy and former research scientist at Duke's Sanford School of Public Policy, is the first to measure the impact on service delivery using data from within organizations whose U.S.-sourced funding was cut and never restored.

HIV prevention, predominantly PrEP (pre-exposure prophylaxis), HIV testing and treatment (antiretroviral therapy; ART) all fell sharply after the 2025 PEPFAR (President's Emergency Plan for AIDS Relief) and USAID (US Agency for International Development) stop-work orders and had not recovered by March 2026, despite a humanitarian waiver meant to protect lifesaving services.

The study shows that when the United States froze foreign aid in January 2025 and halted work under PEPFAR and USAID, HIV service providers in Uganda and Zimbabwe lost more than funding. They lost the systems that helped keep prevention, testing and treatment services running for people at highest risk of HIV.

S. funding withdrawal actually did for those most vulnerable to HIV and at the forefront of the epidemic.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.